Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | STTK |
---|---|---|
09:32 ET | 84244 | 1.415 |
09:34 ET | 830998 | 1.56 |
09:36 ET | 12017 | 1.56 |
09:39 ET | 462177 | 1.54 |
09:41 ET | 388381 | 1.59 |
09:43 ET | 360569 | 1.73 |
09:50 ET | 371208 | 1.8001 |
09:52 ET | 363560 | 1.9199 |
09:54 ET | 344087 | 1.86 |
09:56 ET | 325995 | 1.97 |
09:57 ET | 280072 | 2.12 |
10:03 ET | 133903 | 2.01 |
10:10 ET | 308866 | 1.84 |
10:12 ET | 472942 | 2 |
10:14 ET | 158192 | 2 |
10:15 ET | 76815 | 2 |
10:17 ET | 164453 | 1.98 |
10:19 ET | 70174 | 1.95 |
10:21 ET | 82155 | 1.975 |
10:24 ET | 493264 | 2.08 |
10:26 ET | 187163 | 2.08 |
10:28 ET | 62743 | 2.005 |
10:30 ET | 168944 | 2 |
10:32 ET | 86823 | 2.02 |
10:33 ET | 75755 | 1.9709 |
10:35 ET | 176367 | 2.05 |
10:37 ET | 66258 | 2.03 |
10:39 ET | 28689 | 2 |
10:42 ET | 65251 | 1.98 |
10:44 ET | 23947 | 1.995 |
10:46 ET | 50895 | 1.98 |
10:48 ET | 43138 | 2 |
10:50 ET | 60231 | 1.98 |
10:51 ET | 17561 | 1.989 |
10:53 ET | 34839 | 1.9601 |
10:55 ET | 37601 | 2 |
10:57 ET | 17017 | 2 |
11:00 ET | 29021 | 2.0199 |
11:02 ET | 33769 | 1.97 |
11:04 ET | 12950 | 1.99 |
11:06 ET | 27979 | 1.98 |
11:08 ET | 30094 | 1.99 |
11:09 ET | 11700 | 2 |
11:11 ET | 9040 | 2 |
11:13 ET | 12240 | 2 |
11:15 ET | 20295 | 2 |
11:18 ET | 46035 | 1.981 |
11:20 ET | 117931 | 1.985 |
11:22 ET | 310674 | 2 |
11:24 ET | 34282 | 1.9989 |
11:26 ET | 18252 | 1.99 |
11:27 ET | 30640 | 1.9929 |
11:29 ET | 13785 | 2.0099 |
11:31 ET | 42336 | 2.01 |
11:33 ET | 9148 | 2 |
11:36 ET | 32420 | 2.005 |
11:38 ET | 9709 | 1.995 |
11:40 ET | 6022 | 1.995 |
11:42 ET | 16304 | 2.002 |
11:44 ET | 25253 | 2 |
11:45 ET | 9489 | 2 |
11:47 ET | 6444 | 1.995 |
11:49 ET | 12977 | 1.995 |
11:51 ET | 12116 | 1.99 |
11:54 ET | 38344 | 1.97 |
11:56 ET | 15059 | 1.995 |
11:58 ET | 29267 | 2 |
12:00 ET | 15048 | 1.995 |
12:02 ET | 4563 | 1.995 |
12:03 ET | 7493 | 2 |
12:05 ET | 9250 | 2 |
12:07 ET | 35381 | 2 |
12:09 ET | 15585 | 1.9801 |
12:12 ET | 5472 | 2 |
12:14 ET | 36017 | 2 |
12:16 ET | 6098 | 1.995 |
12:18 ET | 4200 | 2 |
12:20 ET | 12351 | 2 |
12:21 ET | 2941 | 2.005 |
12:23 ET | 19961 | 2.01 |
12:25 ET | 4409 | 2.015 |
12:27 ET | 40840 | 2.068 |
12:30 ET | 19048 | 2.085 |
12:32 ET | 10515 | 2.075 |
12:34 ET | 15203 | 2.04 |
12:36 ET | 4520 | 2.04 |
12:38 ET | 11125 | 2 |
12:39 ET | 30927 | 2.0001 |
12:41 ET | 900 | 2 |
12:43 ET | 24306 | 2 |
12:45 ET | 1205 | 2.01 |
12:48 ET | 1700 | 2 |
12:50 ET | 6896 | 2.005 |
12:52 ET | 2186 | 2.01 |
12:54 ET | 800 | 2.005 |
12:56 ET | 1900 | 2.0075 |
12:57 ET | 2167 | 2.005 |
12:59 ET | 14865 | 2.005 |
01:01 ET | 16559 | 2.005 |
01:03 ET | 7700 | 2.005 |
01:06 ET | 1350 | 2.01 |
01:08 ET | 1100 | 2.01 |
01:10 ET | 3726 | 2.02 |
01:12 ET | 700 | 2.01 |
01:14 ET | 8918 | 2.018 |
01:15 ET | 5649 | 2 |
01:17 ET | 2587 | 2 |
01:19 ET | 300 | 2 |
01:21 ET | 102503 | 2 |
01:24 ET | 111787 | 1.98 |
01:26 ET | 57329 | 1.985 |
01:28 ET | 5900 | 1.9831 |
01:30 ET | 7930 | 2 |
01:32 ET | 10251 | 2.0003 |
01:33 ET | 1100 | 2.005 |
01:35 ET | 2961 | 2.008 |
01:37 ET | 16407 | 1.995 |
01:39 ET | 1331 | 1.99 |
01:42 ET | 17091 | 2 |
01:44 ET | 2800 | 2 |
01:46 ET | 1500 | 1.995 |
01:48 ET | 818 | 1.99 |
01:50 ET | 2500 | 1.995 |
01:51 ET | 2100 | 1.995 |
01:53 ET | 1830 | 1.995 |
01:55 ET | 1678 | 1.99 |
01:57 ET | 3446 | 1.99 |
02:00 ET | 33184 | 1.99 |
02:02 ET | 60593 | 2 |
02:04 ET | 7295 | 2 |
02:06 ET | 1658 | 1.995 |
02:08 ET | 33267 | 1.99 |
02:09 ET | 7673 | 1.99 |
02:11 ET | 4000 | 1.99 |
02:13 ET | 85015 | 1.99 |
02:15 ET | 73800 | 2 |
02:18 ET | 81105 | 1.92 |
02:20 ET | 83396 | 1.97 |
02:22 ET | 11300 | 1.98 |
02:24 ET | 502 | 1.95 |
02:26 ET | 13862 | 1.97 |
02:27 ET | 3290 | 1.98 |
02:29 ET | 13906 | 1.97 |
02:31 ET | 6988 | 1.98 |
02:33 ET | 2723 | 1.99 |
02:36 ET | 1350 | 1.98 |
02:40 ET | 605 | 1.97 |
02:42 ET | 17486 | 1.965 |
02:44 ET | 15574 | 1.98 |
02:45 ET | 7393 | 1.9501 |
02:47 ET | 300 | 1.97 |
02:49 ET | 552 | 1.97 |
02:51 ET | 3055 | 1.97 |
02:54 ET | 777 | 1.97 |
02:56 ET | 5807 | 1.9509 |
02:58 ET | 3747 | 1.955 |
03:02 ET | 51562 | 1.97 |
03:03 ET | 22428 | 1.975 |
03:05 ET | 19088 | 1.98 |
03:07 ET | 13448 | 1.98 |
03:09 ET | 26108 | 2 |
03:12 ET | 22274 | 1.99 |
03:14 ET | 32677 | 1.995 |
03:16 ET | 11200 | 1.99 |
03:18 ET | 24744 | 1.985 |
03:20 ET | 14715 | 1.97 |
03:21 ET | 18124 | 1.97 |
03:23 ET | 18492 | 1.975 |
03:25 ET | 8891 | 1.99 |
03:27 ET | 10462 | 1.99 |
03:30 ET | 31609 | 1.955 |
03:32 ET | 6940 | 1.955 |
03:34 ET | 8913 | 1.96 |
03:36 ET | 4856 | 1.96 |
03:38 ET | 15693 | 1.97 |
03:39 ET | 128713 | 1.97 |
03:41 ET | 7235 | 1.965 |
03:43 ET | 7975 | 1.9689 |
03:45 ET | 8804 | 1.965 |
03:48 ET | 6667 | 1.97 |
03:50 ET | 14327 | 1.97 |
03:52 ET | 18447 | 1.97 |
03:54 ET | 11013 | 1.965 |
03:56 ET | 14755 | 1.965 |
03:57 ET | 469022 | 1.965 |
03:59 ET | 126264 | 1.92 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Shattuck Labs Inc | 91.6M | -1.0x | --- |
Beyondspring Inc | 97.1M | -6.0x | --- |
Avalo Therapeutics Inc | 87.1M | -0.1x | --- |
Oramed Pharmaceuticals Inc | 97.8M | 4.8x | --- |
Sagimet Biosciences Inc | 100.4M | -2.6x | --- |
Leap Therapeutics Inc | 92.2M | -1.2x | --- |
Shattuck Labs, Inc. is a clinical-stage biotechnology company. The Company is engaged in the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease. Its lead product candidate, SL-172154, is designed to simultaneously inhibit the CD47/SIRPa macrophage checkpoint interaction and activate the CD40 costimulatory receptor to induce an antitumor immune response. It is conducting a Phase IA/B clinical trial in patients with acute myeloid leukemia (AML) and HR-MDS. It has completed the Phase IA dose-escalation portion of this clinical trial and are enrolling patients in the Phase IB expansion cohorts evaluating SL-172154 in combination with azacitidine in frontline HR-MDS or frontline TP53 mutant (TP53m) AML. It has developed the ARC platform to address the need for a single therapeutic that consolidates multiple immune functions.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $91.6M |
---|---|
Revenue (TTM) | $4.1M |
Shares Outstanding | 47.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.82 |
EPS | $-1.85 |
Book Value | $3.06 |
P/E Ratio | -1.0x |
Price/Sales (TTM) | 22.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -2,195.81% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.